Detailed information on the research project currently underway. We encourage you to bookmark these pages and check back often. Updates will be added periodically with new information on status, newly-released data, and clinical trial results. Back to New Hair Loss Research Pipeline
SM04554 is a topical compound that modulates the WNT pathway. The WNT pathway is one of the primary signalling pathways that regulate the self-renewal and differentiation of adult stem cells. It also plays other important roles: from hair follicle cycling to hair follicle morphogenesis.
Samumed believes that the ability to modulate the WNT pathway can present a significant opportunity for the treatment of Androgenetic Alopecia, resulting in more hair growth.
Redefining Health Through Tissue Regeneration
10-01-16: Samumed Includes Hair Loss in Regenerative Medicine Platform